These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7516429)

  • 21. Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects.
    Pratt AG; Isaacs JD
    Best Pract Res Clin Rheumatol; 2014 Aug; 28(4):651-9. PubMed ID: 25481556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?
    Girelli F; Foschi FG; Bedeschi E; Calderoni V; Stefanini GF; Martinelli MG
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):127-30. PubMed ID: 15180353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Occurrence of monoclonal rheumatoid factor in most rheumatoid sera].
    Swierczyńska Z; Kosowska E
    Reumatologia; 1972; 10(4):269-80. PubMed ID: 4630247
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis.
    Slack SL; Mannik M; Dale BA
    J Rheumatol; 1998 May; 25(5):847-51. PubMed ID: 9598878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rheumatoid factors: what's new?
    Westwood OM; Nelson PN; Hay FC
    Rheumatology (Oxford); 2006 Apr; 45(4):379-85. PubMed ID: 16418203
    [No Abstract]   [Full Text] [Related]  

  • 26. [Early diagnosis of rheumatoid arthritis with a test based upon a specific antigen: cyclic citrullinated peptide].
    van Venrooij WJ; van de Putte LB
    Ned Tijdschr Geneeskd; 2003 Feb; 147(5):191-4. PubMed ID: 12645351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course and prognosis in seropositive and seronegative rheumatoid arthritis.
    Sahatçiu-Meka V; Rexhepi S; Kukeli A; Manxhuka-Kërliu S; Pallaskas K; Murtezani A; Rexhepi M; Rexhepi B
    Reumatizam; 2013; 60(1):19-24. PubMed ID: 24003679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis.
    Solanki K; Spellerberg M; Chapman P; Moller P; O'Donnell J
    N Z Med J; 2004 Oct; 117(1203):U1097. PubMed ID: 15477921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Position of seronegative chronic polyarthritis].
    Müller W; Langness U; Petersen KF
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2252-5. PubMed ID: 4176712
    [No Abstract]   [Full Text] [Related]  

  • 30. Rheumatoid factor and antikeratin antibody are independent from presence of DR4 or DR1 in rheumatoid arthritis.
    Cantagrel A; Constantin A; Vincent C; Abbal M; Laroche M; Ohayon E; Serre G; Mazières B
    Rev Rhum Engl Ed; 1999 Jan; 66(1):20-3. PubMed ID: 10036694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT; Wiik A; Pedersen M; Hedegaard CJ; Vestergaard BF; Gislefoss RE; Kvien TK; Wohlfahrt J; Bendtzen K; Frisch M
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X; Coenen D; Fieuws S; Verschueren P; Westhovens R; Blanckaert N
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract]   [Full Text] [Related]  

  • 33. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.
    Kaipiainen-Seppanen O; Kautiainen H
    J Rheumatol; 2006 Nov; 33(11):2132-8. PubMed ID: 17014003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantigens and immune pathways in rheumatoid arthritis.
    Corrigall VM; Panayi GS
    Crit Rev Immunol; 2002; 22(4):281-93. PubMed ID: 12678429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
    Lequerré T; Jouen F; Brazier M; Clayssens S; Klemmer N; Ménard JF; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    Rheumatology (Oxford); 2007 Mar; 46(3):446-53. PubMed ID: 16899502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
    Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
    J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis.
    Kopp S; Alstergren P
    Mediators Inflamm; 2002 Aug; 11(4):211-7. PubMed ID: 12396472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States.
    Sokka T; Pincus T
    J Rheumatol; 2009 Jul; 36(7):1387-90. PubMed ID: 19411389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CCP antibodies: the new rheumatoid factor in the serology of rheumatoid arthritis.
    van Venrooij WJ; Vossenaar ER; Zendman AJ
    Autoimmun Rev; 2004 Jun; 3 Suppl 1():S17-9. PubMed ID: 15309772
    [No Abstract]   [Full Text] [Related]  

  • 40. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
    Schellekens GA; de Jong BA; van den Hoogen FH; van de Putte LB; van Venrooij WJ
    J Clin Invest; 1998 Jan; 101(1):273-81. PubMed ID: 9421490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.